Chipmaker Qualcomm has escalated its patent battle with Apple suing Foxconn and three other Taiwanese manufacturers that supply iPhone and iPad components for not paying royalties.
Apple filed a lawsuit against Qualcomm in January, accusing it of overcharging for chips and refusing to pay some $1 billion in rebates – a move that came days after the U.S. government accused the chipmaker of using anticompetitive tactics to maintain a monopoly over key semiconductors in mobile phones.
Qualcomm has called Apple’s suit baseless and has said the iPhone maker was encouraging regulatory attacks on its business.
On Wednesday, Qualcomm said in its complaint that Apple had advised the four contract manufacturers to withhold royalty payments and agreed to indemnify them against any damages resulting from the breach of their agreements with Qualcomm.
It did not disclose the sum of the alleged unpaid royalties in the complaint which was filed in the United States District Court for the Southern District of California. Qualcomm is seeking an order for the suppliers to comply with contractual obligations as well as damages.
Full Content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas